Your browser doesn't support javascript.
loading
Excellent Prognosis of Low-Risk Myelodysplastic Syndromes (MDS) Without Detectable Myeloid-Related Mutations.
Polprasert, Chantana; Niparuck, Pimjai; Rattanathammethee, Thanawat; Chuncharunee, Suporn; Kobbuaklee, Sirorat; Songserm, Kritanan; Suksusut, Amornchai; Trithiphen, Sasinipa; Lanamtieng, Theerin; Kongkiatkamon, Sunisa; Chanswangphuwana, Chantiya; Lawasut, Panisinee; Bunworasate, Udomsak; Rojnuckarin, Ponlapat.
Affiliation
  • Polprasert C; Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand; Research Unit in Translational Hematology, Chulalongkorn University, Bangkok, Thailand.
  • Niparuck P; Department of Medicine, Faculty of Medicine, Mahidol University Ramathibodi hospital, Bangkok, Thailand.
  • Rattanathammethee T; Department of Medicine, Faculty of Medicine, Chiang Mai University, Chiangmai, Thailand.
  • Chuncharunee S; Department of Medicine, Faculty of Medicine, Chiang Mai University, Chiangmai, Thailand.
  • Kobbuaklee S; Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand; Research Unit in Translational Hematology, Chulalongkorn University, Bangkok, Thailand.
  • Songserm K; Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
  • Suksusut A; Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
  • Trithiphen S; Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
  • Lanamtieng T; Department of Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
  • Kongkiatkamon S; Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand; Research Unit in Translational Hematology, Chulalongkorn University, Bangkok, Thailand.
  • Chanswangphuwana C; Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand; Research Unit in Translational Hematology, Chulalongkorn University, Bangkok, Thailand.
  • Lawasut P; Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand; Research Unit in Translational Hematology, Chulalongkorn University, Bangkok, Thailand.
  • Bunworasate U; Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand; Research Unit in Translational Hematology, Chulalongkorn University, Bangkok, Thailand.
  • Rojnuckarin P; Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital, Bangkok, Thailand; Research Unit in Translational Hematology, Chulalongkorn University, Bangkok, Thailand. Electronic address: rojnuckarinp@gmail.com.
Clin Lymphoma Myeloma Leuk ; 22(5): e293-e299, 2022 05.
Article in En | MEDLINE | ID: mdl-34840089
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Myelodysplastic Syndromes / Leukemia, Myeloid, Acute Type of study: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Year: 2022 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Myelodysplastic Syndromes / Leukemia, Myeloid, Acute Type of study: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Year: 2022 Type: Article